PresentationsPeripheralPeripheral PresentationsCX 2019Learning AreasEvents CX 2019: Two-year outcomes from four pooled multicentre RCTs: Safety after treatment with PTX-coated devices
VEITH 2019Editors Pick AorticAortic InterviewsEditor's PickLatest news AorticAorticInterviewsLearning AreasEvents Trials needed to assess whether metformin impedes aneurysm progression in non-diabetic patients
CIRSE 2019Editor's PickEditors Pick HomepageInterviewsLatest news PeripheralPeripheralEditors Pick PeripheralPeripheral InterviewsLearning AreasEvents High-grade evidence supports use of APERTO DCB in vascular access stenosis
CIRSE 2019Editor's PickEditors Pick HomepageInterviewsEditors Pick IRIR InterviewsLatest news IRIRLearning AreasEvents RETNET finds severe hepatobiliary complications with DEB-DOX treatment for neuroendocrine tumours
ESMINT 2019Editor's PickInterviewsEditors Pick HomepageNeuroEditors Pick NeuroNeuro InterviewsLatest news NeuroLearning AreasEvents Surface modification technology could revolutionise ruptured aneurysm treatment globally
Editor's PickInterviewsEditors Pick CardioCardio InterviewsEditors Pick HomepageLatest news CardioCardioLearning AreasEventsEuroPCR 2019 No device related mortality at one year for India’s first trancatheter heart valve
AorticLatest news AorticEditors Pick AorticAortic InterviewsEditor's PickEditors Pick HomepageInterviewsLearning AreasEventsSVS 2019 SVS 2019: Why the proposed NICE guidelines are “not so nice”
Editor's PickInterviewsEditors Pick CardioCardio InterviewsEditors Pick HomepageLatest news CardioCardioLearning AreasEventsEuroPCR 2019 EASTBOURNE registry analysis shows “very good” safety and efficacy of novel sirolimus-coated balloon
Editor's PickCardio InterviewsEditors Pick HomepageCardioInterviewsEditors Pick CardioLearning AreasEventsEuroPCR 2019 EuroPCR 2019: Allegra Transcatheter Heart Valve shows “very good haemodynamic outcomes”
Editor's PickCardio InterviewsEditors Pick HomepageCardioInterviewsEditors Pick CardioLearning AreasEuroPCR 2019 TRILUMINATE trial shows “extremely favourable” results in patients with tricuspid regurgitation
Editor's PickEditors Pick HomepagePeripheralEditors Pick PeripheralPeripheral InterviewsVLF 2019 Sirolimus has “a much wider” safety window and shows fewer local effects than paclitaxel
PeripheralLatest news PeripheralVEITHsymposium 2018 Lutonix BTK IDE: First Level 1 evidence of positive safety and efficacy for DCB below the knee
